Skip to main content

Peer Review reports

From: Novel fusion protein PK5-RL-Gal-3C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity

Original Submission
29 Apr 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
12 Jul 2022 Reviewed Reviewer Report
28 Sep 2022 Reviewed Reviewer Report
17 Dec 2022 Author responded Author comments - Qing Zhang
Resubmission - Version 4
17 Dec 2022 Submitted Manuscript version 4
26 Dec 2022 Author responded Author comments - Qing Zhang
Resubmission - Version 5
26 Dec 2022 Submitted Manuscript version 5
27 Dec 2022 Author responded Author comments - Qing Zhang
Resubmission - Version 6
27 Dec 2022 Submitted Manuscript version 6
16 Jan 2023 Reviewed Reviewer Report
30 Jan 2023 Author responded Author comments - Qing Zhang
Resubmission - Version 7
30 Jan 2023 Submitted Manuscript version 7
Publishing
3 Feb 2023 Editorially accepted
15 Feb 2023 Article published 10.1186/s12885-023-10608-9

You can find further information about peer review here.

Back to article page